Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARVINAS, INC.ARVN · Entity 5355 | Director | June 24, 2026 | June 26, 2026 |
| EXACT SCIENCES CORPEXAS · Entity 56619 | Chief Commercial Officer | April 30, 2024 | May 02, 2024 |
| ILLUMINA, INC.ILMN · Entity 3137 | SVP, Chief Commercial Officer | July 05, 2025 | July 08, 2025 |
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | SVP, Commercial | March 01, 2018 | March 25, 2019 |
| Quanterix CorpQTRX · Entity 6649 | Director · President and CEO | January 19, 2026 | January 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARVINAS, INC.
Report date June 24, 2026 · Filed June 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,572 |
Reported balance
After 2026-06-24 transaction · row 1
1 source rowRow 1 · 2026-06-24 · Grant · Acquired 15,527 · Balance 41,572 F1: The restricted stock units (each, an "RSU") were granted by the Issuer on June 24, 2026 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.05 · Expires 2036-06-23 | Direct | 22,714 |
Reported balance
After 2026-06-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-24 · Grant · Acquired 22,714 · Balance 22,714 F2: This option award was granted on June 24, 2026. The shares underlying the award shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units (each, an "RSU") were granted by the Issuer on June 24, 2026 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date.
F2: This option award was granted on June 24, 2026. The shares underlying the award shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date.
EXACT SCIENCES CORP
Report date April 30, 2024 · Filed May 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,470 |
Reported balance
After 2024-04-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-04-30 · Grant · Acquired 291 · Balance 46,470 F1: Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024. F2: In addition to the shares of Common Stock reported on this Form 4, which total 47,613 shares, Mr. Cunningham also holds, in the aggregate, an additional 90,406 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 47,178 |
Reported balance
After 2024-04-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2024-04-30 · Grant · Acquired 708 · Balance 47,178 F3: Represents shares of common stock purchased through Employee Stock Purchase Plan. F2: In addition to the shares of Common Stock reported on this Form 4, which total 47,613 shares, Mr. Cunningham also holds, in the aggregate, an additional 90,406 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 47,042 |
Reported balance
After 2024-05-01 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2024-05-01 · Sale · Disposed 136 · Balance 47,042 F4: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units. |
| Common StockSEC Table I · non-derivative | IndirectHeld in 401(k) Plan | 571 |
Reported balance
Holding disclosure · report date 2024-04-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 571 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024.
F2: In addition to the shares of Common Stock reported on this Form 4, which total 47,613 shares, Mr. Cunningham also holds, in the aggregate, an additional 90,406 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F3: Represents shares of common stock purchased through Employee Stock Purchase Plan.
F4: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.
ILLUMINA, INC.
Report date July 05, 2025 · Filed July 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,942 |
Reported balance
After 2025-07-05 transaction · row 1
1 source rowRow 1 · 2025-07-05 · Tax withholding · Disposed 4,248 · Balance 41,942 |
| Common StockSEC Table I · non-derivative | IndirectBeneficiary IRA | 70 |
Reported balance
Holding disclosure · report date 2025-07-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 70 |
| Common StockSEC Table I · non-derivative | IndirectIRA | 757 |
Reported balance
Holding disclosure · report date 2025-07-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 757 |
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 3,151 |
Reported balance
Holding disclosure · report date 2025-07-05 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,151 |
| Common StockSEC Table I · non-derivative | IndirectSpouse IRA | 672 |
Reported balance
Holding disclosure · report date 2025-07-05 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 672 |
QUEST DIAGNOSTICS INC
Report date March 01, 2018 · Filed March 25, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,760 |
Reported balance
After 2018-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-03-01 · Gift · Disposed 491 · Balance 37,760 F1: This late reporting of a charitable gift is due to an inadvertent administrative error. F2: This total reflects the current amount of securities beneficially owned by the reporting person as of the filing date of this Form 4. For Form 4s filed by this reporting person since March 1, 2018, this column erroneously included the 491 shares reported herein as a charitable gift. In the Form 4 filed on March 4, 2019, this column also erroneously included 60 shares due to over-reporting of exempt purchases made by the reporting person under the Company's stock purchase plan. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 721 |
Reported balance
Holding disclosure · report date 2018-03-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 721 F3: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. |
Filing footnotes · ownership attribution and instrument terms
F1: This late reporting of a charitable gift is due to an inadvertent administrative error.
F2: This total reflects the current amount of securities beneficially owned by the reporting person as of the filing date of this Form 4. For Form 4s filed by this reporting person since March 1, 2018, this column erroneously included the 491 shares reported herein as a charitable gift. In the Form 4 filed on March 4, 2019, this column also erroneously included 60 shares due to over-reporting of exempt purchases made by the reporting person under the Company's stock purchase plan.
F3: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
Quanterix Corp
Report date January 19, 2026 · Filed January 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2030-01-20 | Direct | 813,750 |
Reported balance
After 2026-01-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-19 · Grant · Acquired 813,750 · Balance 813,750 F1: Each performance-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The performance-based RSUs vest upon the volume-weighted average price of the Issuer's common stock meeting certain thresholds within a four-year period, except as provided for under Section 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026. |
| Time-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2030-01-20 | Direct | 1,883,750 |
Reported balance
After 2026-01-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-19 · Grant · Acquired 1,070,000 · Balance 1,883,750 F2: Each time-based RSU represents a contingent right to receive one share of the Issuer's common stock. The time-based RSUs vest as to one-fourth of the total number of shares on each of January 19, 2027, January 19, 2028, January 19, 2029 and January 19, 2030, except as provided for under Section 8(d) or 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each performance-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The performance-based RSUs vest upon the volume-weighted average price of the Issuer's common stock meeting certain thresholds within a four-year period, except as provided for under Section 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026.
F2: Each time-based RSU represents a contingent right to receive one share of the Issuer's common stock. The time-based RSUs vest as to one-fourth of the total number of shares on each of January 19, 2027, January 19, 2028, January 19, 2029 and January 19, 2030, except as provided for under Section 8(d) or 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2019 Filed Feb 28, 2019 22:11 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,144 | $86.51 | $98,967.44 |
DisclosureSEC source: 0001022079-19-000068 · wf-form4_155139190410701.xml · nonDerivative · entry 3 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,259 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:11 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 352 | $87.06 | $30,645.12 |
DisclosureSEC source: 0001022079-19-000068 · wf-form4_155139190410701.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,403 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:11 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,112 | $87.84 | $97,678.08 |
DisclosureSEC source: 0001022079-19-000068 · wf-form4_155139190410701.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,755 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 23:19 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 326 | $88.23 | $28,762.98 |
DisclosureSEC source: 0001022079-19-000052 · wf-form4_155130957438717.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,867 F2 · shares: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 23:19 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 431 | $88.24 | $38,031.44 |
DisclosureSEC source: 0001022079-19-000052 · wf-form4_155130957438717.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,193 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 00:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 398 | $88.39 | $35,179.22 |
DisclosureSEC source: 0001022079-19-000034 · wf-form4_155114139123355.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,624 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 23:13 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 40,765 | $0.00 Strike: $86.63 | $0.00 |
DisclosureSEC source: 0001022079-19-000019 · wf-form4_155070441642215.xml · derivative · entry 3 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,765 Underlying: Common Stock · 40,765 shares Expires 2029-02-18 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 23:13 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 3,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000019 · wf-form4_155070441642215.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,022 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 20:52 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 40,328 | $71.17 Strike: $71.17 | $2,870,143.76 |
DisclosureSEC source: 0001022079-18-000153 · wf-form4_153142872668242.xml · derivative · entry 4 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,328 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 20:52 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 40,328 | $112.00 | $4,516,736.00 |
DisclosureSEC source: 0001022079-18-000153 · wf-form4_153142872668242.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,261 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 20:52 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 40,328 | $71.17 | $2,870,143.76 |
DisclosureSEC source: 0001022079-18-000153 · wf-form4_153142872668242.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 38,928 | $66.51 Strike: $66.51 | $2,589,101.28 |
DisclosureSEC source: 0001022079-18-000151 · wf-form4_153082307077479.xml · derivative · entry 11 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,464 Underlying: Common Stock · 38,928 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F11 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 21,294 | $52.17 Strike: $52.17 | $1,110,801.51 |
DisclosureSEC source: 0001022079-18-000151 · wf-form4_153082307077479.xml · derivative · entry 10 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,294 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F10 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 781 | $110.12 | $86,006.84 |
DisclosureSEC source: 0001022079-18-000151 · wf-form4_153082307077479.xml · nonDerivative · entry 8 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,261 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F7 · price: This transaction was executed in multiple trades at prices ranging from $110.08 to $110.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F8 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 7,066 | $109.63 | $774,624.38 |
DisclosureSEC source: 0001022079-18-000151 · wf-form4_153082307077479.xml · nonDerivative · entry 7 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,850 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F6 · price: This transaction was executed in multiple trades at prices ranging from $109.08 to $110.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,583 | $110.07 | $614,498.48 |
DisclosureSEC source: 0001022079-18-000151 · wf-form4_153082307077479.xml · nonDerivative · entry 6 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,916 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F5 · price: This transaction was executed in multiple trades at prices ranging from $110.00 to $110.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 33,345 | $109.60 | $3,654,478.62 |
DisclosureSEC source: 0001022079-18-000151 · wf-form4_153082307077479.xml · nonDerivative · entry 5 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,499 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F4 · price: This transaction was executed in multiple trades at prices ranging from $109.00 to $110.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 38,928 | $66.51 | $2,589,101.28 |
DisclosureSEC source: 0001022079-18-000151 · wf-form4_153082307077479.xml · nonDerivative · entry 4 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,496 | $110.12 | $164,742.51 |
DisclosureSEC source: 0001022079-18-000151 · wf-form4_153082307077479.xml · nonDerivative · entry 3 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,916 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F3 · price: This transaction was executed in multiple trades at prices ranging from $110.07 to $110.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 19,798 | $109.64 | $2,170,692.32 |
DisclosureSEC source: 0001022079-18-000151 · wf-form4_153082307077479.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,412 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $109.07 to $110.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 21,294 | $52.17 | $1,110,801.51 |
DisclosureSEC source: 0001022079-18-000151 · wf-form4_153082307077479.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Disposition to issuerCommon Stock | 5,393 | $101.00 | $544,693.00 |
DisclosureSEC source: 0001022079-18-000087 · wf-form4_152038309986714.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,916 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 10,949 | $101.00 | $1,105,849.00 |
DisclosureSEC source: 0001022079-18-000087 · wf-form4_152038309986714.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,266 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 01, 2018 Filed Mar 25, 2019 20:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GiftCommon Stock | 491 | $104.78 | $51,444.53 |
DisclosureSEC source: 0001022079-19-000096 · wf-form4_155354617623001.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,760 F1 · kind: This late reporting of a charitable gift is due to an inadvertent administrative error. F2 · balance_after: This total reflects the current amount of securities beneficially owned by the reporting person as of the filing date of this Form 4. For Form 4s filed by this reporting person since March 1, 2018, this column erroneously included the 491 shares reported herein as a charitable gift. In the Form 4 filed on March 4, 2019, this column also erroneously included 60 shares due to over-reporting of exempt purchases made by the reporting person under the Company's stock purchase plan. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 556 | $101.43 | $56,395.08 |
DisclosureSEC source: 0001022079-18-000060 · wf-form4_151994016573443.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,317 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,212 | $101.43 | $122,933.16 |
DisclosureSEC source: 0001022079-18-000049 · wf-form4_151976728775436.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,873 Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 387 | $102.69 | $39,741.03 |
DisclosureSEC source: 0001022079-18-000049 · wf-form4_151976728775436.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,085 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 33,103 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000026 · wf-form4_151925955726503.xml · derivative · entry 3 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,103 Underlying: Common Stock · 33,103 shares Expires 2028-02-19 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000026 · wf-form4_151925955726503.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,472 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:07 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 6,492 | $98.12 | $636,995.04 |
DisclosureSEC source: 0001022079-17-000093 · wf-form4_148857880856322.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,052 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:07 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 12,520 | $98.12 | $1,228,462.40 |
DisclosureSEC source: 0001022079-17-000093 · wf-form4_148857880856322.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,498 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:46 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 585 | $96.42 | $56,405.70 |
DisclosureSEC source: 0001022079-17-000083 · wf-form4_148849115841920.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,978 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 638 | $95.68 | $61,043.84 |
DisclosureSEC source: 0001022079-17-000065 · wf-form4_148831815219006.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,563 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 37,565 | $95.80 Strike: $95.80 | $3,598,539.18 |
DisclosureSEC source: 0001022079-17-000043 · wf-form4_148789141113641.xml · derivative · entry 3 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,565 Underlying: Common Stock · 37,565 shares Expires 2027-02-21 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 3,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000043 · wf-form4_148789141113641.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,201 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,278 | $93.85 | $119,940.30 |
DisclosureSEC source: 0001022079-17-000019 · wf-form4_148719446873187.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,069 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.